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Electrospinning was used to produce carvedilol-loaded Soluplus polymer nanofibers using a 
systematic approach. Miscibility between drug and polymer was determined through 
calculation of the interaction parameter, χ, and the difference between the total solubility 
parameters, ∆δt. A solubility map for Soluplus was obtained by examining different solvent 
systems, carrying out electrospinning, and characterizing the nanofibers formed. Miscibility 
studies showed that carvedilol and Soluplus can form a miscible system (χ = -2.3054; ∆δt <7.0 
MPa1/2). Based on the Soluplus solubility map, acetone: chloroform (90:10; w/w) represents a 
suitable solvent system for electrospinning of carvedilol-loaded Soluplus nanofibers. Scanning 
electron microscopy of these nanofiber samples showed smooth surface morphology. The 
nanofibers had a regular cylindrical morphology. Beads appeared along the nanofibers more 
frequently in formulations with lower percentages of carvedilol. Differential scanning 
calorimetry showed no melting endothermic peak for carvedilol, which suggests its complete 
conversion from the crystalline to the amorphous form (at polymer: carvedilol 1:1). The 
infrared spectrum of the carvedilol-loaded Soluplus nanofibers showed no characteristic 
carvedilol peak at 3344.5 cm−1, which suggests interactions between carvedilol and Soluplus. 
Dissolution studies of these nanofibers showed improved pure carvedilol dissolution 
properties, with >85% of the carvedilol released in the first 15 min, versus 20% for pure 
carvedilol. The use of miscibility analysis and polymer solubility studies demonstrate great 
technological potential to tackle the challenge for inadequate dissolution of poorly water-
soluble drugs. 
Keywords: poorly soluble drugs; ; ; ; ; , solvent mapping, electrospinning, solid dispersions, 
solubility enhancement, interaction parameter 
  
1. Introduction 
Electrospinning has become one of the most used modern methods for nanofiber production 
for different fields of application (Reneker and Yarin, 2008). Electrospinning is also one of the 
most frequently used techniques for preparation of solid dispersions of poorly soluble drugs 
and polymers. During electrospinning, a polymer solution or ‘melt’ is subjected to very high 
electrostatic forces. This induces a charge on the surface of the liquid. Mutual charge repulsion 
causes a force directly opposite to the surface tension. As the intensity of the electric field is 
increased, the hemispherical surface of the fluid at the tip of the capillary tube elongates to 
form a conical shape known as the Taylor cone (the base region). With increasing field, a 
critical value is attained when the repulsive electrostatic force overcomes the surface tension 
and a charged jet of fluid is ejected from the tip of the Taylor cone. The ejection of the polymer 
solution from a nozzle is followed by random deposition of the polymer nanofibers on an 
electrically grounded collector (Luo et al., 2010; Pham et al., 2006).  
A large number of factors can influence the critical quality attributes of the final product 
here, the nanofibers, such as nanofiber diameter and morphology, and number of beads on the 
nanofiber surface. These factors include the formulation parameters (e.g., type and 
concentration of polymer, solvent and solution properties), the process parameters (e.g., 
applied voltage, flow rate, collector distance, size of nozzle orifice), and the ambient conditions 
(e.g., relative humidity, temperature) (Pelipenko et al., 2015; Luo et al., 2010; Wannatong et 
al., 2004). A careful balance between these factors thus needs to be achieved to obtain stable 
electrospinning rather than electrospraying. The main difference in electrospraying is that the 
ejected jet breaks down into droplets, usually as a consequence of using a lower concentration 
of polymer solution than what is used in electrospinning. Consequently, electrospinning 
produces nanofibers while particles are dominant with electrospraying (Chakraborty et al., 
2009). During electrospinning, a stable Taylor cone needs to be obtained, which again depends 
on a number of parameters (Reneker and Chun, 1996; Pham et al., 2006). Apart of solution 
properties, several process parameters may have the influence on the electrospinning, and they 
need to be monitored. For example, if higher voltage is applied, it can result in smaller and less 
stabile Taylor cone, but also will lead to greater stretching of the solution and to reduction of 
the fiber diameter. Also, for a given voltage, there is a corresponding flow rate, if a stabile 
Taylor cone is to be maintained, where the increase of the flow rate can lead to increase in the 
fiber diameter. This indicates that all parameters are connected and have complex influence on 
the electrospinning (Ramakrishna, 2005). Thus polymer solutions that are considered suitable 
for electrospinning need to provide continuous nanofiber production, a stable Taylor cone, 
uniform nanofiber morphology, and minimal ‘beads-on-a-string’ structure (Luo et al., 2010; 
Mahalingam et al., 2015; Pham et al., 2006).  
Nanofibers obtained by electrospinning basically represent solid dispersions that can 
improve the dissolution properties of poorly soluble drugs (Vo et al., 2013; Nagy et al., 2012, 
2015; Paaver et al., 2014). The phase behavior of a drug and polymer system can be very 
complicated, as the drug can be present in a crystalline form (i.e., as one or more polymorphic 
forms), or partially or completely amorphous forms (Vasconcelos et al., 2007). The degree of 
miscibility between drug and polymer in a blended system is extremely important for 
stabilization of the amorphous drug–polymer system, as it is generally believed that miscibility 
at the molecular level is necessary to achieve maximum physical stabilization, as well as 
enhanced solubility (Marsac et al., 2006; Djuris et al., 2013; Meng et al., 2015). One of the 
methods for miscibility evaluation is based on determination of the Flory–Huggins interaction 
parameter, χ. This can be achieved through a description of the mixing thermodynamics in drug 
and excipient systems using Flory–Huggins lattice theory and the melting point depression 
method. Another approach for miscibility evaluation is based on the group contribution 
method, as modified by Hansen, and this is based on determination of the difference in the total 
solubility parameter, Δδt, between the two components (Meng et al., 2015).  
At the same time, the solubility parameters can be useful for selection of the appropriate 
solvent for a polymer, to ensure successful electrospinning (Luo et al., 2012). A suitable solvent 
system for an active pharmaceutical ingredient and a selected polymer needs to be based on a 
solvent that can dissolve them both, and that has further properties that are relevant for the 
electrospinning (e.g., its relative permittivity, dielectric constant, evaporation rate). Solvents 
with different solubility properties can influence the polymer chain conformation and 
viscoelasticity, the critical minimum concentration of the polymer in solution, the nanofiber 
diameter, the loaded drug crystallinity, and the electrospun polymeric nanofiber tensile strength 
and morphology (Mahalingam et al., 2015).  
Literature sources and technical reports offer different ways to estimate and illustrate 
solubility parameters, which includes the triangular graph (Barton, 1983; Burke, 1984), which 
is frequently the main tool used to select solvents for electrospinning (Hansen, 2007; Luo et 
al., 2010, 2012). Based on the suitable range of values of dielectric constant of solvents within 
the surface drawn in the triangular graph, solvents can be defined in terms of how well they 
dissolve the active pharmaceutical ingredient and the polymer. By overlapping the desired 
properties of potential solvents, the most suitable for electrospinning with the selected active 
pharmaceutical ingredient and polymer can be determined. However, the literature has noted 
frequently that although a solvent can dissolve a polymer of interest well, this does not 
guarantee that the resulting solution can be used to make nanofibers by electrospinning (Luo 
et al., 2010).  
Thus considering all of the characteristics mentioned above, it is necessary to apply a 
more organized approach to reach the definition of the final product in the easiest and most 
consistent way. Apart from the solubility issues, there are also a great number of material 
attributes and process parameters that need to be taken into consideration; however, more 
importantly, these should not be looked at separately, but be part of a systematic procedure.  
The aim of the present study was to apply miscibility preformulation studies to prepare 
and characterize nanofibers by electrospinning with carvedilol and Soluplus polymer. 
Although carvedilol and Soluplus have been investigated in studies on electrospinning (Nagy 
et al., 2012; Paaver et al, 2014; Balogh et al., 2015), to the best of our knowledge there have 
been no previous reports of combined miscibility studies as applied to the production of solid 
dispersions in the form of nanofibers. The miscibility of carvedilol and Soluplus polymer was 
thus analyzed through determination of their solubility and interaction parameters, with these 
solubility parameters further used for construction of the polymer solubility map. A suitable 
solvent system for Soluplus polymer was determined using a triangular graph based on the 
solubility parameters, which was supported also by the relevant carvedilol solubility and 
relative permittivity for electrospinning. The successful electrospinning of these carvedilol-
loaded Soluplus nanofibers was followed by their characterization.  
2. Materials and methods 
2.1. Materials 
Carvedilol (European Pharmacopoeia, vol. 8) was used as a model drug and it was obtained 
from commercial supplier (Hemofarm, Belgrade, Serbia). Polyethylene glycol–polyvinyl 
caprolactam–polyvinyl acetate grafted copolymer (Soluplus) was kindly donated by the 
manufacturer (BASF, Germany). Acetic acid, acetone, acetonitrile, 1-buthanol, chloroform, 
ethanol, ethylene glycol, formic acid, glycerol, methanol, 1-propanol, 2-propanol, methyl 
isobutyl ketone, ethyl acetate, and hydrochloric acid were from Sigma-Aldrich (Poole, UK).  
2.2. Investigation of carvedilol–Soluplus miscibility 
2.2.1. Determination of the interaction parameter 
Physical mixtures of carvedilol and Soluplus were prepared to determine the interaction 
parameter, χ, based on Flory–Huggins lattice theory. These were prepared as 10 g of each 
mixture by manual addition of carvedilol and Soluplus to different carvedilol percentages, as 
(in g, with percentage carvedilol indicated): 0.5:9.5 (5%); 1:9 (10%); 2:8 (20%); 3:7 (30%); 
4:6 (40%); 5:5 (50%); 6.5:3.5 (65%); and 8:2 (80%). 
These physical mixtures underwent thermal analysis by differential scanning 
calorimetry (DSC; see section 2.4.3.2.) The onset of melting for the physical mixtures was 
taken as the extrapolated onset of the bulk melting endotherm. The Flory–Huggins interaction 
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where Tmix and Tpure are the melting points of the physical mixture and the pure drug, 
respectively, ΔHfus is the heat of fusion of the pure drug, 𝜙API and 𝜙polymer are the volume 
fractions of the drug (i.e., active pharmaceutical ingredient) and polymer, respectively, and m 
is the ratio of the volume of the polymer to that of the drug. χ is an interaction parameter that 
accounts for the enthalpy of the mixing, and it provides an indication of the drug–polymer 
miscibility. Tmix and Tpure were obtained from the thermograms. These data are given as a 
function of the square of the volume fraction of the polymer from the rest of Equation (1), 
where the interaction parameter was calculated as the slope of the fitted curve presented by this 
function. 
2.2.2. Determination of solubility parameters 
For determination of the solubility parameters, those of Hansen were used (Hansen, 2007). The 
total solubility parameter δt was determined from the contribution of interactions between the 
dispersion forces, δd, the polar interactions, δp, and the hydrogen bonding, δh, of the functional 
groups. The solubility parameters for carvedilol were calculated using the group-contribution 
method of Stefanis and Panayiotou (2012). The molecular structure of each organic compound 
can be described using two kinds of functional groups: first-order groups (e.g., CH3–, –CH2–, 
C≡C), which describe the basic molecular structure of a compound; and second-order groups 
(e.g., (CH3)2–CH–, (CH3)3–C–, CH3(CO)CH2–), which significantly improve the accuracy of 
predictions (Stefanis and Panayiotou, 2012). The Hansen solubility parameters for carvedilol 
were calculated according to Equations (2) to (4), which apply for values >3 MPa1/2: 
 δd = (
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where Ci is the contribution of the first-order group of type i that appears Ni times in the 
compound, and Dj is the contribution of the second-order group of type j that appears Mj times. 
The values for each group for the calculation of the carvedilol solubility parameters were 
obtained from the literature (Stefanis and Panayiotou, 2012). The solubility parameters for 
Soluplus were also obtained from the literature (Djuris et al., 2013). The difference between 
the total solubility parameters, ∆δt, of the drug and the polymer was determined by calculation 
of the total solubility parameter for the drug and polymer according to Equation (5):  
 δt2 = δd2 + δp2 + δh2 (5). 
The drug–polymer miscibilities were classified on the basis of the difference, ∆δt, 
between the total solubility parameters of the drug and the polymer.  
2.3. Mapping the solubility region of Soluplus on the triangular graph 
Based on preliminary experiments where different amounts of Soluplus were dissolved in 
chosen solvents, and on a literature review, 20% (w/w) Soluplus was chosen as the optimal 
polymer concentration for this purpose. The solvent positions on the triangular graph are 
identified by their fractional parameter values, which can be obtained from the literature 
(Barton, 1983) or calculated as shown for the example in Table 1. These fractional parameters 
were suggested by Teas (1968), as fd, fp, and fh, and they can be derived mathematically from 
the dispersion forces component δd, the polar force component δp, and the hydrogen bonding 
component δh of the Hansen parameters, respectively. The triangular graph expresses the 
fractional parameters as a ternary plot that is drawn as a triangle. Each side of this graph 
represents a distinct variable and has a scale from 0 to 100 (Barton, 1983). The solubility of 
20% (w/w) Soluplus was tested for 15 different solvents. The mixtures were stirred with a 
magnetic stirring bar. The degree of swelling or dissolution was visually assessed after stirring 
for 10 min, 1 h, and 24 h. The observed solubility was categorized and recorded as ‘partial’ or 
‘high’. The solubility map of Soluplus was constructed by drawing a contour area around points 
with high 24-h solubility test results of the selected solvents on the triangular graph. Further 
selection of the optimal solvent system for electrospinning of carvedilol and Soluplus polymer 
here was based on the dielectric constant and the possibility of the solvent system to dissolve 
carvedilol (from values reported in the literature or determined experimentally), as well as on 
the results obtained from the triangular graph (Smallwood, 1996). The solvent systems from 
the contoured area in the triangular graph in which carvedilol was soluble also underwent 
electrospinning (data not shown). Five solvent systems were chosen considering the overlap of 
these desired properties, in terms of the suitability for dissolving carvedilol, and the 
convenience of the dielectric constant for electrospinning using the solvents mapped on the 
triangular graph. Electrospinning was then performed for these five solvent systems.  
a, according to Teas (1968) 
2.4. Preparation of carvedilol–Soluplus solid dispersions by electrospinning  
2.4.1. Preparation of the Soluplus polymer solution 
According to the mapping on the triangular graph, the dielectric constant, and the carvedilol 
solubility, the solvent mixture of acetone and chloroform in the weight ratio of 9:1 was used 
for preparation of the 20% (w/w) Soluplus solution. The solution was stirred for 2 h using a 
magnetic stirrer, at room temperature. Carvedilol was then added to obtain 5%, 10%, 20%, 
30%, 40% and 50% (w/w) solutions in the 20% (w/w) Soluplus, based on the dry weight of the 
Soluplus polymer, and the solutions were stirred for an additional hour prior to electrospinning.  
2.4.2. Electrospinning  
Electrospinning of the carvedilol–Soluplus solutions was performed using an electrospinner 
(Fluidnatek LE-100; Bioinici, Valensia, Spain) with the process parameters set-up according 
to the carvedilol percentages, as shown in Table 2. For all of the experiments, the nozzle 
diameter was 0.6 mm and the collector distance was set at 15 cm. The temperature and relative 
humidity were strictly controlled, at 25 °C and 45%, respectively. The solvent for all of these 
formulations was acetone: chloroform, 9:1 (w/w). 
2.4.3. Nanofiber characterization  
The nanofibers obtained in the solvent system screening phase were evaluated using optical 
microscopy (Carl Zeiss Jena, Germany). The nanofibers produced were also characterized in 
detail by scanning electron microscopy (section 2.4.3.1.), DSC (section 2.4.3.2.), Fourier 
transform infrared spectroscopy (FTIR; section 2.4.3.3.), and in-vitro dissolution (section 
2.4.3.4.). 
2.4.3.1. Scanning electron microscopy  
Morphological examination of the electrospun nanofibers was performed using scanning 
electron microscopy (Supra35 VP; Carl Zeiss, Oberkochen, Germany) operated at an 
accelerating voltage of 1 kV and with a secondary-electron detector. The nanofibers were fixed 
onto metal studs with double-sided conductive tape, with no coating applied prior to imaging. 
The diameters of 100 randomly selected nanofibers were measured using the ImageJ 1.44p 
software (National Institutes of Health, USA), for the mean nanofiber diameter. 
2.4.3.2. Differential scanning calorimetry  
Differential scanning calorimetry was used for characterization of the solid state and 
identification of the crystal and/or amorphous states of carvedilol. DSC was performed using 
a DSC 1 STARe system (Mettler Toledo GmbH Analytical, Giessen, Germany) under a pure 
nitrogen flux of 50 mL/min, and with a heating rate from 25 °C to 200 °C of 10 °C/min. Each 
sample was accurately weighed (6-10 mg) in an aluminum pan, which was then crimped and 
sealed. Temperature calibration was carried out using indium.  
2.4.3.3. Fourier transform infrared spectroscopy 
Fourier transform infrared spectroscopy was used to qualitatively characterize the interactions 
between carvedilol and Soluplus. The FTIR spectra of carvedilol, Soluplus, and the carvedilol-
loaded Soluplus nanofibers were produced using an attenuated total reflectance accessory 
(Nexus, Thermo Nicolet, Madison, USA), in the range of 600 cm-1 to 4000 cm-1, and with a 
resolution of 2 cm-1. 
2.4.3.4. In-vitro dissolution  
In-vitro dissolution studies were carried out in 0.1 N hydrochloric acid (900 mL) at 37 ±0.5 °C 
using a United States Pharmacopeia method II dissolution tester (USP II, Erweka DT 600; 
Hausenstamm, Germany). Soluplus nanofibers containing 12.5 mg carvedilol were gently 
placed in modified sinkers and put in the vessel. The paddle rotation was 50 rpm, and aliquots 
of dissolution medium were withdrawn over a total period of 1 h (at 5, 10, 15, 20, 30, 45, 60 
min). The carvedilol content was determined using a UV/VIS spectrophotometer (Evolution 
300; Thermo Fisher Scientific, Loughborough, USA), at a detection wavelength of 241 nm. 
3. Results and discusion  
3.1. Carvedilol and Soluplus miscibility 
The first method used for estimation of carvedilol and Soluplus miscibility was based on 
determination of the Flory–Huggins interaction parameter and the melting point depression 
phenomena, through examination of the physical mixtures prepared. Thermal analysis was 
carried out, and the DSC thermograms of pure carvedilol and Soluplus and the carvedilol–
Soluplus physical mixtures are shown in Figure 1.  
The temperature of the onset of the carvedilol melting point was determined from these 
thermograms (Fig. 1). Initially, these data showed that this decreased with increased Soluplus 
content, which was already indicative of miscibility between carvedilol and Soluplus (Fig. 2.). 
From 10% to 20% carvedilol (Fig. 2, F2/F3), the change in the temperature of the onset of the 
carvedilol melting point was greater, so additional formulations containing 12.5%, 15%, and 
17.5% carvedilol were prepared and examined to define more precisely the behavior and 
changes in this parameter (Fig. 2, F1p, F2p, F3p). The decreasing trend in the temperature of 
the onset of the carvedilol melting point was confirmed from the changes seen for these 
additional formulations.  
The linear relationship over this range of the polymer weight fractions allowed for 
estimation of the interaction parameter, χ (Fig. 3). A positive χ indicates immiscibility, while a 
negative χ usually indicates miscibility of a system. Quantitatively, a greater negative χ 
indicates higher miscibility (Marsac et al., 2006, 2009; Meng et al., 2015). The slope of the 
fitted line shown in Figure 3 defines χ, which was calculated as -2.305. This negative value of 
χ indicates miscibility of carvedilol and Soluplus.  
The second approach to analyze carvedilol–Soluplus miscibility was to calculate the 
difference between the corresponding solubility parameters, as indicated by Equation (5). Here, 
for ∆δt <7.0 MPa1/2, miscibility is likely to occur, whereas for ∆δt >7.0 MPa1/2, it is not 
(Greenhalgh et al., 1999). The Hansen solubility parameters for Soluplus were taken from the 
literature (Djuris et al., 2013), and for carvedilol they were calculated using Equations (2) to 
(4), as given in Table 3. According to the differences between these solubility parameters for 
carvedilol and Soluplus, the predominant types of interactions in this system are dispersion 
forces and hydrogen bonding. The difference in the total solubility parameters, ∆δt, of 
carvedilol and Soluplus was 2.9 MPa1/2, which is below the border for miscibility between two 
materials, and thus it is very likely that miscibility will occur (Greenhalgh et al., 1999). This is 
supported on the basis that Soluplus is an excipient with amphiphilic properties that was 
developed as a matrix polymer for solid solutions, and it can increase the solubility of poorly 
soluble active pharmaceutical ingredients by forming miscible systems (Hardung et al., 2010).  
At this point, according to these descriptive and numerical methods, these data showed 
that the carvedilol–Soluplus system indeed promotes miscibility; i.e., carvedilol and Soluplus 
are miscible. 3.2. Mapping the solubility region of Soluplus on the triangular graph 
As the solvent positions on the triangular graph are unique and invariable, if a given polymer 
is tested for solubility across a selection of solvents while other variables are kept constant, 
such as the solution concentration, operating temperature, and pressure constant, the solubility 
region of the polymer can be defined on the triangular graph. This empirically determined 
solubility region, i.e., the range of the solvents on the triangular graph, provides a valuable 
means for selection of a solvent system that can dissolve the chosen polymer and will thus be 
suitable for electrospinning (Luo et al, 2010). Solvents that lie in the contoured area on the 
graph can be further analyzed from the aspect of their suitability for electrospinning with the 
chosen active pharmaceutical ingredient.  
Based on 15 different solvent systems with diverse solubility parameters and different 
functional groups, the triangular graph for Soluplus was constructed (Fig. 4). During the testing 
of the Soluplus solubility in the chosen solvents/ solvent mixtures, partial or high solubility of 
Soluplus over the 24-h testing period was observed, mainly due to the polymer amphiphilic 
properties. In Figure 4, the filled-in symbols represent solvents where Soluplus is highly 
soluble, while the open symbols represent solvents where Soluplus was partially soluble. Thus 
the shaded area in Figure 4 includes the solvents that have the required solubility parameters 
for dissolving the Soluplus polymer.  
These solvents given in the triangular graph of Figure 4 were then investigated in more 
detail. Their dielectric constants were defined (Smallwood, 1996), and the solvents with very 
high (>35) or very low (<15) dielectric constants (e.g., water, acetic acid, chloroform) were 
eliminated from the investigation, based on problems observed in the literature and on our 
experience. Literature data also showed that polycaprolactone nanofibers of <100 nm diameter 
were obtained when the dielectric constant of the solvent system used was approximately 19, 
and when this increased, the diameter of these nanofibers decreased (Luo et al., 2012).  
Following this selection, the remaining potential solvents were compared in terms of 
their carvedilol solubility, with the solvents for carvedilol indicated as “S” in Table 4, and those 
showing little or no carvedilol solubility indicated as “I”. (Table 4). The final selection for the 
suitability for electrospinning was thus defined by the solvents in which carvedilol can dissolve 
(Table 4, acetone, chloroform, acetone: chloroform 90:10 [w/w], acetone: chloroform 70:30 
[w/w], ethanol, methanol).  
These five chosen solvent systems were then used for electrospinning of carvedilol-
loaded Soluplus nanofibers. Their suitability here was defined by the stability of the Taylor 
cone during the electrospinning, and by the appearance of the nanofibers obtained under optical 
microscopy (i.e., presence of beading) (Fig. 5). The solution with pure chloroform was 
eliminated because of its high evaporation rate, which resulted in the occasional drying of the 
nanofibers at the needle tip, and also because of the unstable process and the associated toxicity. 
Large differences between the solubility parameters of Soluplus and the solvent system were 
responsible for the beads-on-a-string morphology (Wannatong et al., 2004).  
Charges present during electrospinning have greater effects on a polar solvent than a 
nonpolar solvent. The dielectric constant is related to the dipole moment, and it generally 
reflects the polarity of a molecule, which is also reflected in a higher value of the fractional 
parameter, fp. This is a better predictor of electrospinning productivity than the dipole moment 
or other solvent properties (e.g., boiling point, density) (Wanatong et al., 2004).  
Carbon tetrachloride does not show polarity, and it has not been reported as a successful 
solvent for electrospinning (Wannatong et al., 2004; Son et al., 2004). It is considered that a 
solvent with a higher dielectric constant has a higher net charge density in solution. As the 
charges carried by the jet increase during electrospinning, higher elongation forces are imposed 
by the jet under the electrical field, which results in smaller beads and thinner nanofiber 
diameter (Son et al., 2004).  
The chosen electrospinning systems with solvent dielectric constants of approximately 
19 produced nanofibers, while for the acetone–Soluplus solution (dielectric constant, 20.6), 
beads were observed. This was most likely because of the low boiling point of acetone, which 
caused the nozzle to become clogged up, producing an unstable process, and deformed 
nanofiber morphology (Augustine et al., 2016; Jaeger et al., 1998). In this phase, the 9:1 
mixture (w/w) of acetone and chloroform was seen to be optimal in terms of the stability of the 
electrospinning and the appearance of the nanofibers in the preliminary testing. The 
combination of these two solvents changed the properties of the final solvent system, which 
overcame the solvent disadvantages and allowed stable electrospinning. This approach thus 
provided the possibility to develop a binary solvent system for the formation of nanofibers by 
electrospinning. The solubility–spinnability map simplified the solvent selection process by 
allowing mixed solvent systems to be developed for electrospinning.  
a, S, soluble; I not soluble 
3.3. Preparation of carvedilol-loaded Soluplus nanofibers by electrospinning  
During the electrospinning, this selected solvent system (i.e., acetone: chloroform, 9:1 [w/w]) 
provided a stable Taylor cone and a stable process overall. Here, this showed that a maximum 
of 50% carvedilol (based on the dry weight of the Soluplus), could be incorporated into the 
carvedilol-loaded Soluplus nanofibers.  
3.3.1. Morphology of the nanofibers 
Scanning electron microscopy of the nanofibers is shown in Figure 6. The surface morphology 
of the nanofibers was smooth, but a trend for beads appearance was noted as more likely in 
formulations with the lower percentages of carvedilol. Pure Soluplus nanofibers were easy to 
produce with no bead formed (data not shown). The obtained fibers had a regular, cylindrical 
morphology. The average diameter of the nanofibers was <1 µm for all of the formulations 
tested from Table 2. The stable electrospinning and stable Taylor cone, and the morphologic 
characteristics of the nanofibers, indicated that this chosen solvent system in combination with 
the Soluplus polymer is suitable for these purposes.  
3.3.2. Differential scanning calorimetry  
Differential scanning calorimetry was performed for the nanofibers, and representative 
thermograms for up to 50% carvedilol are shown in Figure 7. This analysis was carried out to 
evaluate the transformation of the carvedilol during the formation of these carvedilol-loaded 
Soluplus nanofibers by electrospinning, as a solid dispersion. The isolated peak for carvedilol 
was not seen in any of these samples (Fig. 7), which implies that the carvedilol was in an 
amorphous form or was dissolved in the Soluplus, as was predicted by the evaluation of the 
carvedilol–Soluplus miscibility. As illustrated in Figure 7, the pure carvedilol was 
characterized by a single, sharp melting endothermic peak at 119.12 °C, which corresponded 
to the melting point of carvedilol, thus confirming its crystalline form. Based on the DSC 
measurements for all of the formulations given in Table 2, it can be concluded that the 
carvedilol-loaded Soluplus nanofibers produced contained carvedilol in a noncrystalline form, 
or to be more precise, in its amorphous form, for the range up to the 1:1 carvedilol:Soluplus 
ratio (i.e., 50% carvedilol) used here. It was not possible to incorporate higher levels of 
carvedilol into these Soluplus nanofibers by electrospinning.  
3.3.3. Fourier transform infrared spectroscopy  
Fourier transform infrared spectroscopy was performed to study the interactions between 
carvedilol and Soluplus in the carvedilol-loaded Soluplus nanofibers obtained. Formulations 
with the lowest (N1, 5%) and highest (N6, 50%) percent of carvedilol are presented on the 
figure, as well as the Soluplus and carvedilol (Fig. 8).  
The FTIR spectrum of pure carvedilol showed an intense, well-defined, characteristic 
infrared absorption band at 3344.5 cm−1, which corresponded to the N–H stretching vibration 
of the secondary amine. Three intense absorption bands were at 2993.87 cm−1 and 2924.5 cm−1, 
and at 1099 cm−1, which corresponded to C–H aliphatic stretching and to C–O stretching, 
respectively. In addition, there were other sharp bands at 1500 cm−1 to 1400 cm−1, as C–C 
aromatic stretching, and 1253 cm−1, as C–N stretching.  
Soluplus showed peaks at 3448.72 cm−1, as O–H stretching, 2927.98 cm−1, as aromatic 
C–H stretching, 1735.93 cm−1 and 1635.23 cm−1, as C–O stretching, and 1477.21 cm−1, as C–
O–C stretching.  
The FTIR spectra of these carvedilol-loaded Soluplus nanofibers in the form of this 
solid dispersion did not show the characteristic peak for carvedilol at 3344.5 cm−1 that 
corresponds to the N–H stretching. This can be attributed to a possible interaction between the 
–NH group of carvedilol and the –CO group of Soluplus, which would lead to the formation of 
an amide group in the nanofibers, as reported previously (Shamma and Basha, 2013). 
3.3.4. In-vitro dissolution study 
Carvedilol is a poorly soluble active substance, and this formulation as nanofibers with 
Soluplus showed improved dissolution properties according to in-vitro tests (Fig. 9). It can be 
noted that for all six of these formulations, >85% of the carvedilol was released in the first 15 
min, and >95% at the end of the 1-h dissolution testing. The dissolution studies of pure 
carvedilol showed <40% released in 1 h, which demonstrates that these carvedilol-loaded 
Soluplus nanofibers have improved carvedilol dissolution. Thus these dissolution studies 
showed high percentages of dissolved carvedilol, which was most likely as a result of the solid 
dispersions formed by the electrospinning.  
High percentages of incorporated carvedilol have been reported in the literature, at up 
to 60%, based on the dry weight of the polymer, polycaprolactone, but with higher percentages 
of chloroform used as solvent (Potrč et al., 2015). According to the data shown in Figure 9, the 
largest differences in the dissolution profiles between these formulations was in the first 15 
min of dissolution. After these 15 min, the further release of carvedilol was similar across all 
of the formulations here, which ranged from 5% to 50% carvedilol. These data thus 
demonstrate that when the solid dispersion samples (i.e., the carvedilol-loaded Soluplus 
nanofibers) contain up to 50% carvedilol, immediate release of carvedilol can occur, and the 
carvedilol dissolution properties are improved in comparison to pure carvedilol.  
4. Conclusions 
The present study investigated different steps in the preformulation phase for obtaining 
different forms of carvedilol-loaded Soluplus nanofibers using electrospinning. Estimation of 
the miscibility of drug and polymer shown that a certain level of miscibility of carvedilol and 
Soluplus was expected and achieved. This justifies the formulation of such solid dispersions 
that contain these two components, in terms of the poor aqueous solubility of carvedilol. The 
Soluplus solubility map was constructed on the triangular graph, and the solvents were also 
assessed in terms of their carvedilol solubility and whether their dielectric constant was 
favorable for the electrospinning. This has not previously been reported in the literature and it 
allowed the formation of a specific database for the active pharmaceutical ingredient (i.e., 
carvedilol) and the chosen specific polymer (i.e., Soluplus) for the electrospinning. Moreover, 
the data obtained from the Soluplus solubility map represents a step forward for estimation of 
the production of nanofibers by electrospinning using other active pharmaceutical ingredients 
that might or might not have similar properties to carvedilol. The approach presented here 
provides a less time-consuming process for the selection of a suitable solvent system.  
It was found that the optimal solvent system for electrospinning of carvedilol and 
Soluplus is acetone: chloroform, 9:1 (w/w). Examination of the morphology of the nanofibers 
obtained showed no defects, and the electrospinning was stable throughout this process. 
Characterization of nanofibers revealed that the carvedilol in the carvedilol-loaded Soluplus 
nanofibers was in its amorphous state, with molecular dispersion throughout the Soluplus 
polymer through the formation of a miscible system. This was practical confirmation of the 
results of miscibility analysis of carvedilol and Soluplus. Also, carvedilol dissolution properties 
were improved, shown through dissolution tests of these carvedilol-loaded Soluplus 
nanofibers. 
Therefore, the data from the present study support this drug formulation design, which 
includes improved prediction of the in-vivo carvedilol dissolution, to help to assure product 
efficacy and safety for patients. 
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Table 1. Calculation of the fractional parameters for a 9:1 solvent mixture of acetone and 
chloroform (Barton, 1983). 
Solvent Fractional parametera calculation 
 fd fp fh 
Chloroform 67 × 1/10 = 6.7 12 × 1/10 = 1.2 21 × 1/10 = 2.1 
Acetone 47 × 9/10 = 42.3 32 × 9/10 = 28.8 21 × 9/10 = 18.9 
Acetone: chloroform, 9:1 42.3 + 6.7 = 49 28.8 + 1.2 = 30 18.9 + 2.1 = 21 
 







5 4 14 
10 2 12 
20 2 14 
30 1 11 
40 2 13 
50 1 11 
 
Table 3. The solubility parameters for carvedilol and Soluplus. 
Compound Solubility parameter (MPa1/2) 
 δd δp δh δt 
Carvedilol  19.5 7.6 7.6 22.3 
Soluplus 17.4 0.3 8.6 19.4 
 
Table 4. The chosen solvents and their properties. 






Acetone 20.6 S Formed beads 
Chloroform 4.9 S Unsuitable 
Acetone: chloroform, 9:1 (w/w) 19.03 S Formed nanofibers 
Acetone: chloroform, 7:3 (w/w) 15.89 S Formed beads 
Ethanol 24.5 S Formed beads 
Methanol 32.6 S Formed particles 
Acetic acid 6.2 I Unsuitable 
Water 79 I Unsuitable 
 
  
Figr-10Figure 1. Thermograms of carvedilol, Soluplus® and physical mixtures. These were 
prepared as 10 g of each pure mixture and by manual addition of carvedilol and Soluplus to 
different carvedilol percentages (g, percentage carvedilol): F1, (5%); F2, (10%); F3, (20%); 
F4, (30%); F5, (40%); F6, (50%); F7, (65%); and F8, (80%). 
Figure 2. Depression of the onset of the carvedilol melting temperature with increase in 
Soluplus volume fraction. As for Figure 1: F1, (5%); F2, (10%); F3, (20%); F4, (30%); F5, 
(40%); F6, (50%); F7, (65%); and F8, (80%). Additional data points: F1p, (12.5%); F2p, 
(15%); F3p, (17.5%). 
Figure 3. Plot used to calculate the carvedilol–Soluplus miscibility interaction parameter χ.  
Figure 4. Triangular graph for determination of the Soluplus solubility map. 
Figure 5. Representative carvedilol-loaded Soluplus nanofibers observed under optical 
microscopy during the solvent selection: (a, a’) ethanol; (b, b’) methanol; (c, c’) acetone, (d, 
d’) acetone: chloroform (90: 10, w/w). 
Figure 6. Representative carvedilol-loaded Soluplus nanofibers observed in scanning electron 
microscopy micrographs, using different percentages of carvedilol (a–f): a) N1, (5%); b) N2, 
(10%); c) N3, (20%); d) N4, (30%); e) N5, (40%); f) N6, (50%). 
Figure 7. Differential scanning calorimetry thermograms for pure carvedilol and Soluplus, and 
for the nanofibers from the different carvedilol percentages (g, percentage carvedilol): N1, 
(5%); N2, (10%); N3, (20%); N4, (30%); N5, (40%); N6, (50%). 
Figure 8. Representative spectra from Fourier transform infrared spectroscopy of carvedilol, 
Soluplus, and the nanofiber with the lowest and highest percent of carvedilol (g, percentage 
carvedilol): N1, (5%); N6, (50%). 
Figure 9. In-vitro dissolution profiles of carvedilol from the nanofibers from the different 
carvedilol percentages (g, percentage carvedilol): N1, (5%); N2, (10%); N3, (20%); N4, (30%); 
N5, (40%); N6, (50%), and for pure carvediol. 
